Stocks of AstraZeneca PLC (NASDAQ:AZN) traded higher last session on Wall Street, up 0.29% to $69.71.
According to the data, AstraZeneca PLC (NASDAQ:AZN) has 30 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $108.54 and a low of $67.54, we find $83.62. Given the previous closing price of $69.51, this indicates a potential upside of 20.3 percent. AZN stock price is now -0.84% away from the 50-day moving average and 0.97% away from the 200-day moving average. The market capitalization of the company currently stands at $217.95B.
A total of 6 analysts have issued a hold rating and 23 have given it a buy rating. Brokers who have rated the stock have averaged $85.09 as their price target over the next twelve months.
A total of 0.50% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in AZN stock. A new stake in AstraZeneca PLC shares was purchased by SOFINNOVA INVESTMENTS, INC. during the first quarter worth $118,334,000. MANNING & NAPIER GROUP, LLC invested $50,537,000 in shares of AZN during the first quarter. In the first quarter, FOLKETRYGDFONDET acquired a new stake in AstraZeneca PLC valued at approximately $28,463,000. BALYASNY ASSET MANAGEMENT L.P. acquired a new stake in AZN for approximately $21,065,000. JANNEY MONTGOMERY SCOTT LLC purchased a new stake in AZN valued at around $14,392,000 in the second quarter. In total, there are 1,297 active investors with 17.90% ownership of the company’s stock.
Wednesday’s opening bell rang with an opening price of $68.95 for AstraZeneca PLC (NASDAQ: AZN). During the past 12 months, AstraZeneca PLC has had a low of $52.65 and a high of $76.56. As of last week, the company has a debt-to-equity ratio of 0.80, a current ratio of 0.90, and a quick ratio of 0.70. According to the stock market information, the enterprise value for the company is $237.84B, which is based on a 35.30 price-to-earnings ratio, a 2.60 price-to-earnings-growth ratio, and a beta of 0.51. The fifty day moving average price for AZN is $70.23 and a two-hundred day moving average price translates $69.10 for the stock.
The latest earnings results from AstraZeneca PLC (NASDAQ: AZN) was released for Jun, 2023. According to the Drug Manufacturers – General Company, earnings per share came in at $1.08, beating analysts’ expectations of $0.95 by 0.13. This compares to $0.12 EPS in the same period last year. The net profit margin was 13.90% and return on equity was 17.00% for AZN. The company reported revenue of $11.42 billion for the quarter, compared to $10.77 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.99 percent. For the current quarter, analysts expect AZN to generate $11.68B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 09/11/2023. Investors who held shares on 08/11/2023 were paid a $0.465 dividend. On an annualized basis, this represents a $1.45 dividend and a 2.08% percent yield. There was an ex-dividend date of 08/10/2023 for this dividend. In terms of dividend payout ratio, AZN is presently at 49.50%.
